BR9510429A - Composto composição farmacêutica processo para produzir o composto e uso do composto - Google Patents

Composto composição farmacêutica processo para produzir o composto e uso do composto

Info

Publication number
BR9510429A
BR9510429A BR9510429A BR9510429A BR9510429A BR 9510429 A BR9510429 A BR 9510429A BR 9510429 A BR9510429 A BR 9510429A BR 9510429 A BR9510429 A BR 9510429A BR 9510429 A BR9510429 A BR 9510429A
Authority
BR
Brazil
Prior art keywords
compound
pct
formula
produce
pharmaceutical composition
Prior art date
Application number
BR9510429A
Other languages
English (en)
Inventor
Hamish Ryder
Stephen James Brocchini
Ian Andrew Pretswell
Sukhjit Hunjan
Philip Anthony Ashworth
Original Assignee
Xenova Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xenova Ltd filed Critical Xenova Ltd
Publication of BR9510429A publication Critical patent/BR9510429A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
BR9510429A 1994-12-23 1995-12-22 Composto composição farmacêutica processo para produzir o composto e uso do composto BR9510429A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9426090.8A GB9426090D0 (en) 1994-12-23 1994-12-23 Pharmaceutical compounds
PCT/GB1995/003029 WO1996020180A1 (en) 1994-12-23 1995-12-22 Piperazine-2,5-dione derivatives as modulators of multidrug resistance

Publications (1)

Publication Number Publication Date
BR9510429A true BR9510429A (pt) 1998-07-07

Family

ID=10766502

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9510429A BR9510429A (pt) 1994-12-23 1995-12-22 Composto composição farmacêutica processo para produzir o composto e uso do composto

Country Status (28)

Country Link
US (1) US5935955A (pt)
EP (1) EP0799210B1 (pt)
JP (1) JPH10511385A (pt)
KR (1) KR100412167B1 (pt)
CN (1) CN1108294C (pt)
AT (1) ATE204569T1 (pt)
AU (1) AU700891B2 (pt)
BG (1) BG63305B1 (pt)
BR (1) BR9510429A (pt)
CA (1) CA2207548A1 (pt)
CZ (1) CZ288935B6 (pt)
DE (1) DE69522342T2 (pt)
DK (1) DK0799210T3 (pt)
ES (1) ES2160726T3 (pt)
FI (1) FI972661A (pt)
GB (2) GB9426090D0 (pt)
HK (1) HK1001974A1 (pt)
HU (1) HUT77740A (pt)
IL (1) IL116526A (pt)
MY (1) MY131762A (pt)
NO (1) NO308532B1 (pt)
NZ (1) NZ297849A (pt)
PL (1) PL186851B1 (pt)
PT (1) PT799210E (pt)
SK (1) SK283385B6 (pt)
UA (1) UA61879C2 (pt)
WO (1) WO1996020180A1 (pt)
ZA (1) ZA9510908B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9708805D0 (en) 1997-05-01 1997-06-25 Smithkline Beecham Plc Compounds
GB9810876D0 (en) 1998-05-20 1998-07-22 Smithkline Beecham Plc Compounds
SK4782001A3 (en) 1998-10-08 2001-11-06 Smithkline Beecham Plc Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents)
EP1210093A4 (en) * 1999-09-03 2005-01-12 Polytherics Ltd DEGRADABLE POLYMERS
US6828412B1 (en) * 1999-09-03 2004-12-07 School Of Pharmacy, University Of London Degradable polymers
EP2266607A3 (en) 1999-10-01 2011-04-20 Immunogen, Inc. Immunoconjugates for treating cancer
ES2294026T3 (es) 2000-09-06 2008-04-01 Ap Pharma, Inc. Polimeros degradables de poliacetal.
US6693099B2 (en) 2000-10-17 2004-02-17 The Procter & Gamble Company Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance
EP1451856A2 (en) * 2001-11-07 2004-09-01 Pharmacia Corporation Methods of promoting uptake and nuclear accumulation of polyamides in eukaryotic cells
US8710062B2 (en) * 2011-03-11 2014-04-29 Taipei Medical University Piperazinedione compounds
CN103396372B (zh) * 2013-08-09 2015-05-20 中国科学院南海海洋研究所 一类2,5-二酮哌嗪衍生物及其制备方法和在制备抗海洋污损生物防除剂中的应用
KR102468480B1 (ko) * 2018-12-27 2022-11-18 홀로스메딕 주식회사 신규한 화합물 및 이를 포함하는 항암 활성 증진용 약학 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4567193A (en) * 1992-07-10 1994-01-31 Laboratoires Glaxo S.A. Anilide derivatives
AU664920B2 (en) * 1992-08-14 1995-12-07 Asahi Breweries, Ltd. Peptide having allergenicity
GB9217331D0 (en) * 1992-08-14 1992-09-30 Xenova Ltd Pharmaceutical compounds
GB9402807D0 (en) * 1994-02-14 1994-04-06 Xenova Ltd Pharmaceutical compounds
GB9410387D0 (en) * 1994-05-24 1994-07-13 Xenova Ltd Pharmaceutical compounds

Also Published As

Publication number Publication date
DE69522342T2 (de) 2002-01-03
KR100412167B1 (ko) 2004-05-27
IL116526A0 (en) 1996-03-31
GB9426090D0 (en) 1995-02-22
ZA9510908B (en) 1996-06-24
ATE204569T1 (de) 2001-09-15
DE69522342D1 (de) 2001-09-27
BG101601A (en) 1998-02-27
CN1108294C (zh) 2003-05-14
NO972938D0 (no) 1997-06-23
FI972661A (fi) 1997-08-22
NO308532B1 (no) 2000-09-25
CA2207548A1 (en) 1996-07-04
AU700891B2 (en) 1999-01-14
CZ190297A3 (cs) 1998-01-14
DK0799210T3 (da) 2001-10-01
EP0799210B1 (en) 2001-08-22
SK83597A3 (en) 1998-04-08
NO972938L (no) 1997-06-23
HUT77740A (hu) 1998-07-28
CZ288935B6 (cs) 2001-09-12
US5935955A (en) 1999-08-10
WO1996020180A1 (en) 1996-07-04
JPH10511385A (ja) 1998-11-04
ES2160726T3 (es) 2001-11-16
MY131762A (en) 2007-08-30
NZ297849A (en) 1999-04-29
PT799210E (pt) 2002-01-30
UA61879C2 (en) 2003-12-15
CN1176637A (zh) 1998-03-18
AU4310296A (en) 1996-07-19
SK283385B6 (sk) 2003-06-03
EP0799210A1 (en) 1997-10-08
GB2311780A (en) 1997-10-08
HK1001974A1 (en) 1998-07-24
FI972661A0 (fi) 1997-06-19
BG63305B1 (bg) 2001-09-28
PL320915A1 (en) 1997-11-10
PL186851B1 (pl) 2004-03-31
IL116526A (en) 1999-11-30
GB9712179D0 (en) 1997-08-13
GB2311780B (en) 1999-03-03

Similar Documents

Publication Publication Date Title
ATE206611T1 (de) Verwendung von mangiferin oder seinen derivaten zur kosmetischen anwendung
BR0008015A (pt) Uso de um composto, composto, composições farmacêuticas, e, processo para preparar um composto
CA2263319A1 (en) Quinazoline derivatives and pharmaceutical compositions containing them
BR9510429A (pt) Composto composição farmacêutica processo para produzir o composto e uso do composto
MX9300552A (es) Derivados de etanolamina
DK0677046T3 (da) Piperazinderivater som 5-HT-antagonister.
SE9701304D0 (sv) Compounds
BR0004535A (pt) Compostos, e, uso dos mesmos.
ES2098023T3 (es) Compuestos de estructura guanidinica y composiciones farmaceuticas que los contienen.
DE69719511D1 (de) Antivirale 2,4-pyrimidindion-derivate und verfahren zu ihrer herstellung
PT92540A (pt) Processo para a preparacao de derivados de anfotericina b
HUP0303137A2 (hu) Kettős hatású antioxidáns és antiaritmiás szerek
ES2149817T3 (es) Piridinas sustituidas, su preparacion y uso farmaceutico.
ES2175337T3 (es) Compuesto bifenilicos y su utilizacion como agentes estrogenicos.
ATE228359T1 (de) Hemmung der leukotrienbiosynthese mittels harnstoffderivaten
ES2120039T3 (es) Nuevos acildipeptidos heterociclicos, procedimientos de preparacion y composiciones farmaceuticas que los contienen.
ECSP972209A (es) Nuevos compuestos, procedimientos para su preparacion, composiciones, farmaceuticas y su uso en terapia

Legal Events

Date Code Title Description
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements